pangea bio
BrazilHealthtech
Pangea Bio is a biotechnology company focused on discovering novel drugs for central nervous system (CNS) disorders. It leverages traditional knowledge and biodiversity, particularly from botanicals, to develop treatments. The company's platform integrates AI (PangeAI team) for drug discovery. Its customers are likely pharmaceutical companies and patients. It operates globally but is headquartered in Brazil.
2 funding rounds tracked. Amounts, dates and investors are available to premium members.
Unlock full funding history
Unlock full funding history
Key people
- Lars Wilde Co-Founder & Chief Executive Officer
- Manon Veraart Co-Founder & Chief Business Officer
- Dr Thomas Pfeiffer Co-Founder & Senior Vice President of Research and Developme
- Julia Wilde Co-Founder & Chief People and Impact Officer